Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
Clinical trial NCT05845268 · UNKNOWN
Trial details
- NCT number
- NCT05845268
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-11-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.